Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

medtas pty ltd - caspofungin acetate, quantity: 77.7 mg - injection, powder for - excipient ingredients: mannitol; sucrose; carbon dioxide; sodium hydroxide; dilute hydrochloric acid - cancigin is indicated for: ? empirical therapy for presumed fungal infections in febrile, neutropenic patients whose fever has failed to respond to broad-spectrum antibiotics ? treatment of: - invasive candidiasis, including candidaemia - oesophageal candidiasis - invasive aspergillosis in patients who are refractory to or intolerant of other therapies.

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

steriscience pty ltd - caspofungin acetate, quantity: 77.7 mg - injection, powder for - excipient ingredients: sucrose; mannitol; carbon dioxide; sodium hydroxide; dilute hydrochloric acid - casfungin is indicated for: ? empirical therapy for presumed fungal infections in febrile, neutropenic patients whose fever has failed to respond to broad-spectrum antibiotics ? treatment of: - invasive candidiasis, including candidaemia - oesophageal candidiasis - invasive aspergillosis in patients who are refractory to or intolerant of other therapies.

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

medtas pty ltd - caspofungin acetate, quantity: 55.5 mg - injection, powder for - excipient ingredients: sucrose; mannitol; carbon dioxide; sodium hydroxide; dilute hydrochloric acid - caspodas is indicated for: ? empirical therapy for presumed fungal infections in febrile, neutropenic patients whose fever has failed to respond to broad-spectrum antibiotics ? treatment of: - invasive candidiasis, including candidaemia - oesophageal candidiasis - invasive aspergillosis in patients who are refractory to or intolerant of other therapies.

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

steriscience pty ltd - caspofungin acetate, quantity: 55.5 mg - injection, powder for - excipient ingredients: mannitol; sucrose; carbon dioxide; sodium hydroxide; dilute hydrochloric acid - casfungin is indicated for: ? empirical therapy for presumed fungal infections in febrile, neutropenic patients whose fever has failed to respond to broad-spectrum antibiotics ? treatment of: - invasive candidiasis, including candidaemia - oesophageal candidiasis - invasive aspergillosis in patients who are refractory to or intolerant of other therapies.

Kanada - angleščina - Health Canada

sterimax inc - caspofungin (caspofungin acetate) - powder for solution - 50mg - caspofungin (caspofungin acetate) 50mg - echinocandins

Kanada - angleščina - Health Canada

sterimax inc - caspofungin (caspofungin acetate) - powder for solution - 70mg - caspofungin (caspofungin acetate) 70mg - echinocandins

Malta - angleščina - Medicines Authority

galenicum health, s.l. avenida diagonal 123, 11ª planta, 08005, barcelona, spain - caspofungin acetate - powder for concentrate for solution for infusion - caspofungin acetate 50 milligram(s) - antimycotics for systemic use

Malta - angleščina - Medicines Authority

galenicum health, s.l. avenida diagonal 123, 11ª planta, 08005, barcelona, spain - caspofungin acetate - powder for concentrate for solution for infusion - caspofungin acetate 70 milligram(s) - antimycotics for systemic use

Malta - angleščina - Medicines Authority

mylan s.a.s. 117 allee des parcs, 69800 saint priest, france - caspofungin acetate - powder for concentrate for solution for infusion - caspofungin acetate 50 milligram(s) - antimycotics for systemic use

Malta - angleščina - Medicines Authority

mylan s.a.s. 117 allee des parcs, 69800 saint priest, france - caspofungin acetate - powder for concentrate for solution for infusion - caspofungin acetate 70 milligram(s) - antimycotics for systemic use